Noticias de KOD_US

Mercado

Noticias del mercado

Últimas noticias sobre KOD_US — 235 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: KOD_US ✕ 235 resultados
30/09/2026 KOD_US — AD HOC NEWS
Kodiak Sciences stock clears a major clinical hurdle

Kodiak Sciences stock has a fresh Phase 3 catalyst after Zenkuda and KSI-501 met DAYBREAK endpoints

30/09/2026 KOD_US — Stock Titan
Funds buy Kodiak Sciences (KOD) shares at average prices reaching $89.86 per share.

Las compras del 28 y 29 de septiembre de 2026 fueron indirectas. No se informó ningún plan de la Regla 10b5-1; el asesor tenía total autoridad para invertir y votar.

30/09/2026 KOD_US — Stock Titan
In 30 transactions, Baker funds bought shares of Kodiak Sciences (KOD).

Weighted-average prices ranged from $61.2104 to $78.5681 per share for September 28, 2026 purchases. No Rule 10b5-1 plan is reported.

30/09/2026 KOD_US — Stock Titan
A stock acquisition changes beneficial ownership by more than 1% at Kodiak Sciences (KOD).

Each reporting person lists 22,049,297 shares; the ownership calculation includes 188,356 vested options held by board member Felix J. Baker.

29/09/2026 KOD_US — MarketBeat
Biotech Stocks To Consider - September 29th

Moderna, uniQure, Amgen, Iovance Biotherapeutics, Summit Therapeutics, Natera, and Kodiak Sciences are the seven Biotech stocks to watch today, according to MarketBeat

29/09/2026 KOD_US — Investorideas.com
Biotech Stock Kodiak Sciences (Nasdaq: KOD) Leads Nasdaq's Monday Gainers; up 177%

Kodiak Sciences (Nasdaq: KOD) closed up 177.96% at $89.92 as Phase 3 DAYBREAK met primary endpoints for Zenkuda and tabirafusp-ted in wet AMD.

29/09/2026 KOD_US — Yahoo Finance
KOD Stock Soars 178% on Positive Wet AMD Data as BLA Filing Nears

Kodiak surges 178% as positive phase III DAYBREAK data show Zenkuda and tabirafusp-ted met key endpoints against Eylea.

Página 6 de 12